ArticleCureus2024

Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review.

Fatima AlKindi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.